Bio-Techne (TECH) Shares Outstanding (2009 - 2026)
Bio-Techne (TECH) posted quarterly Shares Outstanding (Entity) of $156.5 million for Q1 2026, little changed year-over-year from $156.8 million in Q1 2025, and little changed quarter-over-quarter from $155.9 million in Q4 2025.
Bio-Techne (TECH) Shares Outstanding (2009 - 2026) Analysis & Trends
Bio-Techne's Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $156.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.16% year-over-year to $156.5 million; the TTM figure through Mar 2026 stood at $156.5 million (changed 0.16% YoY), while the FY2025 annual figure was $155.0 million, down 2.05% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $156.5 million, roughly flat from $155.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $158.9 million in Q3 2024, with the low at $155.0 million in Q2 2025.
- The 5-year median for Shares Outstanding (Entity) is $157.1 million (2022), against an average of $157.1 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) gained 1.05% in 2022, then slipped 2.05% in 2025.
- Bio-Techne's Shares Outstanding (Entity) stood at $157.1 million in 2022, then increased by 0.03% to $157.1 million in 2023, then gained by 0.49% to $157.9 million in 2024, then slipped by 1.29% to $155.9 million in 2025, then climbed by 0.41% to $156.5 million in 2026.
- Business Quant data shows TECH's Shares Outstanding (Entity) at $156.5 million in Q1 2026, $155.9 million in Q4 2025, and $155.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 156.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.33 Mn |
| Dec 31, 2025 | 155.84 Mn |
| Sep 30, 2025 | 155.46 Mn |
| Jun 30, 2025 | 157.52 Mn |
| Mar 31, 2025 | 157.37 Mn |
| Dec 31, 2024 | 158.43 Mn |
| Sep 30, 2024 | 158.53 Mn |
| Jun 30, 2024 | 157.71 Mn |
| Mar 31, 2024 | 157.31 Mn |
| Dec 31, 2023 | 157.53 Mn |
| Sep 30, 2023 | 158.13 Mn |
| Jun 30, 2023 | 157.18 Mn |
| Mar 31, 2023 | 157.31 Mn |
| Dec 31, 2022 | 157.01 Mn |
| Sep 30, 2022 | 156.93 Mn |
| Jun 30, 2022 | 156.88 Mn |
| Mar 31, 2022 | 157.09 Mn |
| Dec 31, 2021 | 157.24 Mn |
| Sep 30, 2021 | 156.38 Mn |
| Jun 30, 2021 | 154.99 Mn |